Context Therapeutics Inc.
USD0.56
-0.01 (-2.32%)
CEO
Martin A. Lehr
IPO Date
2021-10-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.57
Prev. Close
$0.58
Day Low
$0.55
Day High
$0.62
52W Low
$0.55
52W High
$3.62
Market Cap
$0.05B
Volume
1.68M
| -2.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -201.9% | -149.2% | 0.00 | 3.83 | -0.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -42.7% | -39.1% | 0.00 | 11.80 | -0.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -21.7% | -20.4% | 0.00 | 16.90 | -0.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -39.3% | 1421.7% | -0.35 | 0.04 | 8.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 26.6% | -2333.8% | -0.91 | 0.01 | -8.8 |
| -2.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -13.2% | -12.2% | 0.00 | 13.07 | -2.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -10.7% | -10.1% | 0.00 | 19.09 | -1.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -5.0% | -4.9% | 0.00 | 48.80 | -3.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -3.5% | -3.4% | 0.00 | 35.62 | -4.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -20.8% | -20.2% | 0.00 | 36.91 | -2.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -2.2% | -2.2% | 0.00 | 64.01 | -11.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -43.4% | -33.2% | 0.00 | 4.23 | -1.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -57.0% | -42.1% | 0.00 | 3.83 | -0.7 |